Skip to Content

I-MAX LIGHTENING 5

Medically reviewed on September 28, 2017

Dosage form: cream
Ingredients: HYDROQUINONE 2g in 100g
Labeler: MAXLIFE USA, INC.
NDC Code: 42952-201

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

ACTIVE INGREDIENTS:
HYDROQUINONE USP 2%

PURPOSE:

SKIN LIGHTENING

USES:

FOR THE GRADUAL FADING OF DARK AREAS OF THE SKIN.

WARNINGS:

AVOID CONTACT WITH EYES. SOME USERS MAY EXPERIENCE MILD SKIN IRRITATION.

IF IRRITATION BECOMES SEVERE, STOP USE AND CONSULT A DOCTOR.

THIS PRODUCT IS NOT INTENDED FOR USE IN THE PREVENTION OF SUNBURN AND CONTAINS AN ALPHA HYDROXY ACID (AHA) THAT MAY INCREASE YOUR SKIN'S SENSITIVITY TO THE SUN AND PARTICULARLY THE POSSIBILITY OF SUNBURN. SUN EXPOSURE SHOULD BE LIMITED BY USING A SUNSCREEN AGENT OR PROTECTIVE CLOTHING TO COVER BLEACHED SKIN AFTER TREATMENT IS COMPLETED TO PREVENT DARKENING FROM REOCCURING.

DO NOT USE ON CHILDREN UNDER 12 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR.

DIRECTIONS:

ADULTS: APPLY A SMALL AMOUNT AS A THIN LAYER ON THE AFFECTED AREA TWICE DAILY, OR USE AS DIRECTED BY A DOCTOR. IF NO IMPROVEMENT IS SEEN AFTER 3 MONTHS OF TREATMENT, USE OF THIS PRODUCT SHOULD BE DISCONTINUED. LIGHTENING EFFECT OF THIS PRODUCT MAY NOT BE NOTICEABLE WHEN USED ON VERY DARK SKIN.

CHILDREN UNDER 12 YEARS OF AGE: DO NOT USE UNLESS DIRECTED BY A DOCTOR.

INACTIVE INGREDIENTS:

C13-14 ISOPARAFFIN, CETYL ALCOHOL, ETHYLHEXYLGLYCERIN, ETHYLHEXYL STEARATE, GLYCERIN, GLYCERYL STEARATE, GLYCOLIC ACID, ISOPROPYL MYRISTATE, LAURETH-7, NIACINAMIDE, PANTOTHENIC ACID, PEG-100 STEARATE, PHENOXYETHANOL, POLYACRYLAMIDE, PYRIDOXINE HCL, SODIUM HYDROXIDE, SODIUM METABISULFITE, TETRAHEXYLDECYL ASCORBATE, WATER (AQUA), XANTHAN GUM.

QUESTIONS? 1-323-733-7033

KEEP OUT OF REACH OF CHILDREN.

I-MAX LIGHTENING 5 
hydroquinone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42952-201
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROQUINONE (HYDROQUINONE) HYDROQUINONE2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
C13-14 ISOPARAFFIN 
CETYL ALCOHOL 
ETHYLHEXYLGLYCERIN 
ETHYLHEXYL STEARATE 
GLYCERIN 
GLYCERYL MONOSTEARATE 
GLYCOLIC ACID 
ISOPROPYL MYRISTATE 
LAURETH-7 
NIACINAMIDE 
PANTOTHENIC ACID 
PEG-100 STEARATE 
PHENOXYETHANOL 
POLYACRYLAMIDE (10000 MW) 
PYRIDOXINE HYDROCHLORIDE 
SODIUM HYDROXIDE 
SODIUM METABISULFITE 
TETRAHEXYLDECYL ASCORBATE 
WATER 
XANTHAN GUM 
Packaging
#Item CodePackage Description
1NDC:42952-201-1259 g in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart358A09/18/2012
Labeler - MAXLIFE USA, INC. (785111431)
Establishment
NameAddressID/FEIOperations
CUSTOM RESEARCH LABS INC028611598manufacture(42952-201)

 
MAXLIFE USA, INC.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide